Sex Differences in Liver Cancer Mortality Trends in the US : Role of Cancer Type, Aetiology, and Birth Cohort
Liver International · 2026-04 · 46 (4)
DOI: 10.1111/liv.70574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 26.02.2026. Verfasst von Ugo Fedeli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiological Department, Azienda Zero, Veneto Region, Italy. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Liver cancer mortality (HCC, iCCA) is rising in the U.S., with marked sex disparities linked to hormones and risk factor exposure. This study examines recent trends in mortality by subtype, aetiology, and generation, highlighting their roles in sex‐based differences.
Methods
Mortality data for U.S. residents (1999–2023) were obtained from the CDC WONDER database. Age‐standardised mortality rates were analysed for HCC and iCCA, with HCC deaths further classified by aetiology. Mortality trends were assessed by sex using Joinpoint regression, and age‐, period‐, and birth‐cohort effects were evaluated with constrained generalised linear models.
Results
Between 1999 and 2023, 534 526 liver cancer deaths occurred (353 968 in men; 180 588 in women). Male mortality increased until 2013, plateaued, and declined after 2017, while female mortality continued to rise modestly. For HCC, HCV‐related mortality peaked around 2013 and declined thereafter, coinciding with direct‐acting antiviral introduction. Meanwhile, MASLD‐related mortality rose steadily, becoming the leading reported aetiology in both sexes by 2023. ALD‐related mortality also increased, while HBV‐related mortality remained stable. Cohort analysis revealed excess HCC mortality among those born in the 1940s–1960s. In contrast, iCCA mortality rose continuously in both sexes and across birth cohorts, with sharp increases among women and younger adults. By 2023, iCCA accounted for 44% of female liver cancer deaths.
Conclusions
Liver cancer mortality is declining in men but rising in women. These trends coincide with changes in HCC etiologies along with an increasing contribution of iCCA, particularly in women. Targeted prevention and equitable access to screening are pivotal to reducing mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epidemiological Department, Azienda Zero, Veneto Region, Italy.
- Gastroenterology Unit, Azienda Ospedale-Università Padova, Padua, Italy.
- Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
- Department of Women's and Children's Health - Università Padova, Padua, Italy.
- Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Ugo Fedeli, Elisa Pinto, Alberto Zanetto, Andrew M Moon
Zitieren
APA
Fedeli, U., Battistella, S., Pinto, E., Casotto, V., Zanetto, A., Suraci, C., Marchese, E., Moon, A. M., & Russo, F. P. (2026). Sex Differences in Liver Cancer Mortality Trends in the US : Role of Cancer Type, Aetiology, and Birth Cohort. Liver International, 46(4). https://doi.org/10.1111/liv.70574
Vancouver
Fedeli U, Battistella S, Pinto E, Casotto V, Zanetto A, Suraci C, et al. Sex Differences in Liver Cancer Mortality Trends in the US : Role of Cancer Type, Aetiology, and Birth Cohort. Liver International. 2026;46(4). doi:10.1111/liv.70574
BibTeX
@article{Fedeli2026,
author = {Fedeli, Ugo and Battistella, Sara and Pinto, Elisa and Casotto, Veronica and Zanetto, Alberto and Suraci, Chiara and Marchese, Elena and Moon, Andrew M and Russo, Francesco Paolo},
title = {Sex Differences in Liver Cancer Mortality Trends in the US : Role of Cancer Type, Aetiology, and Birth Cohort},
journal = {Liver International},
year = {2026},
volume = {46},
number = {4},
doi = {10.1111/liv.70574}
}
EUVIMED